David Michael Clark is CPO at AMICUS THERAPEUTICS, INC. (FOLD). They have made 5 open-market trades across 1 company since 2020, most recently 2026-01-03.
CIK 0001755662
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FOLD | 240,309 | $3.5M |
Shares reported on the most recent Form 4, priced at the 2026-01-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FOLD | SELL · 10b5-1 | 2025-12-19 | 2025-12-23 | $14.17 | $727K | +0.5% | +0.4% | +1.4% |
| FOLD | SELL · 10b5-1 | 2025-12-15 | 2025-12-17 | $11.00 | $282K | +30.0% | +30.7% | +31.2% |
| FOLD | SELL · 10b5-1 | 2025-11-24 | 2025-11-26 | $10.10 | $518K | -1.8% | +42.6% | +43.7% |
| FOLD | SELL · 10b5-1 | 2025-11-04 | 2025-11-05 | $9.51 | $488K | +2.4% | +7.6% | +55.2% |
| FOLD | SELL · 10b5-1 | 2024-02-15 | 2024-02-20 | $14.00 | $62K | -1.8% | -13.6% | -27.9% |
| FOLD | SELL · 10b5-1 | 2024-01-08 | 2024-01-09 | $14.00 | $142K | -8.9% | -2.3% | -15.0% |
| FOLD | SELL | 2023-01-18 | 2023-01-19 | $13.50 | $100K | -1.1% | -2.3% | -11.4% |
| FOLD | SELL | 2023-01-06 | 2023-01-06 | $11.87 | $511K | +11.6% | +11.7% | -3.9% |
| FOLD | SELL | 2023-01-03 | 2023-01-04 | $12.03 | $204K | +4.1% | +11.1% | -8.4% |
| FOLD | SELL | 2022-08-05 | 2022-08-09 | $12.50 | $142K | -5.4% | -6.5% | -17.7% |
| FOLD | SELL | 2020-02-12 | 2020-02-14 | $11.00 | $78K | -14.6% | -38.3% | +1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.